About Vertex Pharmaceuticals

Vertex Pharmaceuticals is a biotechnology company that develops and commercializes innovative medicines for the treatment of serious and rare diseases, including cystic fibrosis and other genetic diseases. The company's key products include Kalydeco, Orkambi, and Trikafta, which are cystic fibrosis treatments, as well as its portfolio of other pipeline assets. Vertex's innovative therapies have transformed the treatment landscape for patients with rare and serious diseases, improving their quality of life and life expectancy.